United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$325Mraised across 2 rounds since 2025, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
OrbiMed
RA Capital Management
Janus Henderson Investors
Cormorant Asset Management
Catalio Capital Management
Blue OwlSource recordedSEC filing: $125M sold, first sale Sept 2025
From Star Therapeutics's own website: 1 founder, 3 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
This firm lists Star Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Star Therapeutics's investors include OrbiMed, Janus Henderson Investors, RA Capital Management, Cormorant Asset Management and Catalio Capital Management, and 7 more on record. OrbiMed led its latest round.
Star Therapeutics has raised $325M across 2 rounds since 2025.
Star Therapeutics's most recent round was an Undisclosed round of $200M in Oct 2026, led by OrbiMed.
Its most recent round, $200M in Oct 2026, is also its largest on record.
Star Therapeutics's first round on record, in Sept 2025, was backed by OrbiMed, RA Capital Management and Janus Henderson Investors and 3 others.
Star Therapeutics's latest named round is an Undisclosed round, in Oct 2026.
Star Therapeutics is based in the United States.
OrbiMed led the Undisclosed round in 2026.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
